Skip to main content
SpringerLink
Log in

Gastroesophageal Variceal Bleeding Management

  • Chapter
  • First Online:
The Critically Ill Cirrhotic Patient

Abstract

Gastroesophageal variceal bleeding is one of the major causes of death in patients with cirrhosis. Even though in the last decades survival has been improved due to the widespread adoption of effective treatments and optimization of general medical care, mortality is still significantly high and remains about 15–20% in most recent series. Following the transition into the decompensated stage, cirrhosis progresses more rapidly toward death or liver transplantation, and decompensated patients pose a complex challenge requiring a multidisciplinary approach that is crucial to reduce mortality. The aim of the present chapter is to review the most recent advances in the management of gastroesophageal variceal bleeding, aiming to highlight useful information to aid hepatologists in the clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217–31.

    Article  PubMed  Google Scholar 

  2. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133(2):481–8.

    Article  CAS  PubMed  Google Scholar 

  3. Garcia-Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology. 2010;51(4):1445–9.

    Article  PubMed  Google Scholar 

  4. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 1990;99(5):1401–7.

    Article  CAS  PubMed  Google Scholar 

  5. Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353(21):2254–61.

    Article  CAS  PubMed  Google Scholar 

  6. Vorobioff J, Groszmann RJ, Picabea E, Gamen M, Villavicencio R, Bordato J, et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology. 1996;111(3):701–9.

    Article  CAS  PubMed  Google Scholar 

  7. Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol. 2003;38(3):266–72.

    Article  PubMed  Google Scholar 

  8. D’Amico G, Luca A. Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol. 1997;11(2):243–56.

    Article  PubMed  Google Scholar 

  9. Zoli M, Merkel C, Magalotti D, Gueli C, Grimaldi M, Gatta A, et al. Natural history of cirrhotic patients with small esophageal varices: a prospective study. Am J Gastroenterol. 2000;95(2):503–8.

    Article  CAS  PubMed  Google Scholar 

  10. North Italian Endoscopic Club for the S, Treatment of Esophageal V. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med. 1988;319(15):983–9.

    Article  Google Scholar 

  11. Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet. 2003;361(9361):952–4.

    Article  PubMed  Google Scholar 

  12. D’Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis. 1999;19(4):475–505.

    Article  PubMed  Google Scholar 

  13. de Franchis R, Baveno VIF. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–52.

    Article  PubMed  Google Scholar 

  14. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985;5(3):419–24.

    Article  CAS  PubMed  Google Scholar 

  15. Abraldes JG, Villanueva C, Banares R, Aracil C, Catalina MV, Garci APJC, et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol. 2008;48(2):229–36.

    Article  PubMed  Google Scholar 

  16. D’Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology. 2006;131(5):1611–24.

    Article  PubMed  Google Scholar 

  17. D’Amico G, Pasta L, Morabito A, D’Amico M, Caltagirone M, Malizia G, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014;39(10):1180–93.

    Article  PubMed  Google Scholar 

  18. Moore FA, McKinley BA, Moore EE. The next generation in shock resuscitation. Lancet. 2004;363(9425):1988–96.

    Article  PubMed  Google Scholar 

  19. McCormick PA, Jenkins SA, McIntyre N, Burroughs AK. Why portal hypertensive varices bleed and bleed: a hypothesis. Gut. 1995;36(1):100–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol. 2008;48(Suppl 1):S68–92.

    Article  CAS  PubMed  Google Scholar 

  21. Villanueva C, Balanzo J. Variceal bleeding: pharmacological treatment and prophylactic strategies. Drugs. 2008;68(16):2303–24.

    Article  CAS  PubMed  Google Scholar 

  22. Kravetz D, Bosch J, Arderiu M, Pilar Pizcueta M, Rodes J. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting. Hepatology. 1989;9(6):808–14.

    Article  CAS  PubMed  Google Scholar 

  23. Kravetz D, Sikuler E, Groszmann RJ. Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. Gastroenterology. 1986;90(5 Pt 1):1232–40.

    Article  CAS  PubMed  Google Scholar 

  24. Villanueva C, Ortiz J, Minana J, Soriano G, Sabat M, Boadas J, et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology. 2001;121(1):110–7.

    Article  CAS  PubMed  Google Scholar 

  25. Zimmon DS, Kessler RE. The portal pressure-blood volume relationship in cirrhosis. Gut. 1974;15(2):99–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11–21.

    Article  CAS  PubMed  Google Scholar 

  27. Sayiner M, Younossi ZM. Increasing incidence of nonalcoholic steatohepatitis as an indication for liver transplantation in Australia and New Zealand. Liver Transpl. 2019;25(1):25–34.

    Article  Google Scholar 

  28. Younossi ZM. Non-alcoholic fatty liver disease – a global public health perspective. J Hepatol. 2019;70(3):531–44.

    Article  PubMed  Google Scholar 

  29. Cardenas A, Gines P, Uriz J, Bessa X, Salmeron JM, Mas A, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology. 2001;34(4 Pt 1):671–6.

    Article  CAS  PubMed  Google Scholar 

  30. European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–60.

    Article  Google Scholar 

  31. Duggan JM. Review article: transfusion in gastrointestinal haemorrhage–if, when and how much? Aliment Pharmacol Ther. 2001;15(8):1109–13.

    Article  CAS  PubMed  Google Scholar 

  32. Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009;37(12):3124–57.

    Article  PubMed  Google Scholar 

  33. Roberts I, Evans P, Bunn F, Kwan I, Crowhurst E. Is the normalisation of blood pressure in bleeding trauma patients harmful? Lancet. 2001;357(9253):385–7.

    Article  CAS  PubMed  Google Scholar 

  34. Castaneda B, Morales J, Lionetti R, Moitinho E, Andreu V, Perez-Del-Pulgar S, et al. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats. Hepatology. 2001;33(4):821–5.

    Article  CAS  PubMed  Google Scholar 

  35. American Society of Anesthesiologists Task Force on Perioperative Blood T, Adjuvant T. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology. 2006;105(1):198–208.

    Article  Google Scholar 

  36. Key NS, Negrier C. Coagulation factor concentrates: past, present, and future. Lancet. 2007;370(9585):439–48.

    Article  CAS  PubMed  Google Scholar 

  37. Stroncek DF, Rebulla P. Platelet transfusions. Lancet. 2007;370(9585):427–38.

    Article  PubMed  Google Scholar 

  38. Lisman T, Caldwell SH, Burroughs AK, Northup PG, Senzolo M, Stravitz RT, et al. Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol. 2010;53(2):362–71.

    Article  PubMed  Google Scholar 

  39. Bosch J, Thabut D, Albillos A, Carbonell N, Spicak J, Massard J, et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology. 2008;47(5):1604–14.

    Article  CAS  PubMed  Google Scholar 

  40. Bosch J, Thabut D, Bendtsen F, D’Amico G, Albillos A, Gonzalez Abraldes J, et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology. 2004;127(4):1123–30.

    Article  CAS  PubMed  Google Scholar 

  41. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65(1):310–35.

    Article  PubMed  Google Scholar 

  42. Bendtsen F, D’Amico G, Rusch E, de Franchis R, Andersen PK, Lebrec D, et al. Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: an individual patient based meta-analysis of two controlled trials. J Hepatol. 2014;61(2):252–9.

    Article  CAS  PubMed  Google Scholar 

  43. Violi F, Ferro D, Basili S, Quintarelli C, Saliola M, Alessandri C, et al. Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis. Hepatology. 1992;15(4):672–6.

    Article  CAS  PubMed  Google Scholar 

  44. Piscaglia F, Siringo S, Hermida RC, Legnani C, Valgimigli M, Donati G, et al. Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices. Hepatology. 2000;31(2):349–57.

    Article  CAS  PubMed  Google Scholar 

  45. Primignani M, Dell’Era A, Bucciarelli P, Bottasso B, Bajetta MT, de Franchis R, et al. High-D-dimer plasma levels predict poor outcome in esophageal variceal bleeding. Dig Liver Dis. 2008;40(11):874–81.

    Article  CAS  PubMed  Google Scholar 

  46. Koch DG, Arguedas MR, Fallon MB. Risk of aspiration pneumonia in suspected variceal hemorrhage: the value of prophylactic endotracheal intubation prior to endoscopy. Dig Dis Sci. 2007;52(9):2225–8.

    Article  PubMed  Google Scholar 

  47. Sorbi D, Gostout CJ, Peura D, Johnson D, Lanza F, Foutch PG, et al. An assessment of the management of acute bleeding varices: a multicenter prospective member-based study. Am J Gastroenterol. 2003;98(11):2424–34.

    Article  PubMed  Google Scholar 

  48. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W, Practice Guidelines Committee of the American Association for the Study of Liver D, Practice Parameters Committee of the American College of G. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922–38.

    Article  CAS  PubMed  Google Scholar 

  49. Hwang JH, Shergill AK, Acosta RD, Chandrasekhara V, Chathadi KV, Decker GA, et al. The role of endoscopy in the management of variceal hemorrhage. Gastrointest Endosc. 2014;80(2):221–7.

    Article  PubMed  Google Scholar 

  50. Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1998;27(5):1207–12.

    Article  CAS  PubMed  Google Scholar 

  51. Hou MC, Lin HC, Liu TT, Kuo BI, Lee FY, Chang FY, et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology. 2004;39(3):746–53.

    Article  CAS  PubMed  Google Scholar 

  52. Plessier A, Denninger MH, Consigny Y, Pessione F, Francoz C, Durand F, et al. Coagulation disorders in patients with cirrhosis and severe sepsis. Liver Int. 2003;23(6):440–8.

    Article  PubMed  Google Scholar 

  53. Ruiz-del-Arbol L, Urman J, Fernandez J, Gonzalez M, Navasa M, Monescillo A, et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 2003;38(5):1210–8.

    Article  PubMed  Google Scholar 

  54. Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology. 1995;108(6):1828–34.

    Article  CAS  PubMed  Google Scholar 

  55. Pauwels A, Mostefa-Kara N, Debenes B, Degoutte E, Levy VG. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology. 1996;24(4):802–6.

    CAS  PubMed  Google Scholar 

  56. Tandon P, Abraldes JG, Keough A, Bastiampillai R, Jayakumar S, Carbonneau M, et al. Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics. Clin Gastroenterol Hepatol. 2015;13(6):1189–96.. e2

    Article  PubMed  Google Scholar 

  57. Brown MR, Jones G, Nash KL, Wright M, Guha IN. Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and Clostridium difficile rates. World J Gastroenterol. 2010;16(42):5317–23.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Fernandez J, Ruiz del Arbol L, Gomez C, Durandez R, Serradilla R, Guarner C, et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology. 2006;131(4):1049–56.. quiz 285

    Article  CAS  PubMed  Google Scholar 

  59. D’Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology. 2003;124(5):1277–91.

    Article  PubMed  CAS  Google Scholar 

  60. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40(3):652–9.

    Article  PubMed  Google Scholar 

  61. Avgerinos A, Nevens F, Raptis S, Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet. 1997;350(9090):1495–9.

    Article  CAS  PubMed  Google Scholar 

  62. Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet. 1995;346(8979):865–8.

    Article  CAS  PubMed  Google Scholar 

  63. Wells M, Chande N, Adams P, Beaton M, Levstik M, Boyce E, et al. Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther. 2012;35(11):1267–78.

    Article  CAS  PubMed  Google Scholar 

  64. Feu F, Bordas JM, Garcia-Pagan JC, Bosch J, Rodes J. Double-blind investigation of the effects of propranolol and placebo on the pressure of esophageal varices in patients with portal hypertension. Hepatology. 1991;13(5):917–22.

    Article  CAS  PubMed  Google Scholar 

  65. Walker S, Kreichgauer HP, Bode JC. Terlipressin vs. somatostatin in bleeding esophageal varices: a controlled, double-blind study. Hepatology. 1992;15(6):1023–30.

    Article  CAS  PubMed  Google Scholar 

  66. Seo YS, Park SY, Kim MY, Kim JH, Park JY, Yim HJ, et al. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology. 2014;60(3):954–63.

    Article  CAS  PubMed  Google Scholar 

  67. Azam Z, Hamid S, Jafri W, Salih M, Abbas Z, Abid S, et al. Short course adjuvant terlipressin in acute variceal bleeding: a randomized double blind dummy controlled trial. J Hepatol. 2012;56(4):819–24.

    Article  CAS  PubMed  Google Scholar 

  68. Chitapanarux T, Ritdamrongthum P, Leerapun A, Pisespongsa P, Thongsawat S. Three-day versus five-day somatostatin infusion combination with endoscopic variceal ligation in the prevention of early rebleeding following acute variceal hemorrhage: a randomized controlled trial. Hepatol Res. 2015;45(13):1276–82.

    Article  CAS  PubMed  Google Scholar 

  69. Rengasamy S, Ali SM, Sistla SC, Lakshmi CP, Harichandra Kumar KT. Comparison of 2 days versus 5 days of octreotide infusion along with endoscopic therapy in preventing early rebleed from esophageal varices: a randomized clinical study. Eur J Gastroenterol Hepatol. 2015;27(4):386–92.

    Article  CAS  PubMed  Google Scholar 

  70. Salim A, Malik K, Haq IU, Butt AK, Alam A. Comparison of 12-hour with 72-hour Terlipressin therapy for bleeding esophageal varices. J Coll Physicians Surg Pak. 2017;27(6):334–7.

    PubMed  Google Scholar 

  71. Yan P, Tian X, Li J. Is additional 5-day vasoactive drug therapy necessary for acute variceal bleeding after successful endoscopic hemostasis?: a systematic review and meta-analysis. Medicine (Baltimore). 2018;97(41):e12826.

    Article  CAS  Google Scholar 

  72. Saner FH, Canbay A, Gerken G, Broelsch CE. Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome. Expert Rev Gastroenterol Hepatol. 2007;1(2):207–17.

    Article  CAS  PubMed  Google Scholar 

  73. Escorsell A, Ruiz del Arbol L, Planas R, Albillos A, Banares R, Cales P, et al. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology. 2000;32(3):471–6.

    Article  CAS  PubMed  Google Scholar 

  74. Garcia-Pagan JC, Reverter E, Abraldes JG, Bosch J. Acute variceal bleeding. Semin Respir Crit Care Med. 2012;33(1):46–54.

    Article  PubMed  Google Scholar 

  75. Huang Y, Wang M, Wang J. Hyponatraemia induced by terlipressin: a case report and literature review. J Clin Pharm Ther. 2015;40(6):626–8.

    Article  CAS  PubMed  Google Scholar 

  76. Sola E, Lens S, Guevara M, Martin-Llahi M, Fagundes C, Pereira G, et al. Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension. Hepatology. 2010;52(5):1783–90.

    Article  CAS  PubMed  Google Scholar 

  77. Corley DA, Cello JP, Adkisson W, Ko WF, Kerlikowske K. Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology. 2001;120(4):946–54.

    Article  CAS  PubMed  Google Scholar 

  78. Erstad BL. Octreotide for acute variceal bleeding. Ann Pharmacother. 2001;35(5):618–26.

    Article  CAS  PubMed  Google Scholar 

  79. Jenkins SA, Shields R, Davies M, Elias E, Turnbull AJ, Bassendine MF, et al. A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage. Gut. 1997;41(4):526–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Hsu YC, Lin JT, Chen TT, Wu MS, Wu CY. Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study. Hepatology. 2012;56(2):698–705.

    Article  PubMed  Google Scholar 

  81. Dam G, Vilstrup H, Watson H, Jepsen P. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites. Hepatology. 2016;64(4):1265–72.

    Article  CAS  PubMed  Google Scholar 

  82. O’Leary JG, Reddy KR, Wong F, Kamath PS, Patton HM, Biggins SW, et al. Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis. Clin Gastroenterol Hepatol. 2015;13(4):753–9 e1–2.

    Article  PubMed  CAS  Google Scholar 

  83. Bajaj JS, Acharya C, Fagan A, White MB, Gavis E, Heuman DM, et al. Proton pump inhibitor initiation and withdrawal affects gut microbiota and readmission risk in cirrhosis. Am J Gastroenterol. 2018;113(8):1177–86.

    Article  CAS  PubMed  Google Scholar 

  84. Hsu YC, Chung CS, Tseng CH, Lin TL, Liou JM, Wu MS, et al. Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage. J Gastroenterol Hepatol. 2009;24(7):1294–9.

    Article  PubMed  Google Scholar 

  85. Altraif I, Handoo FA, Aljumah A, Alalwan A, Dafalla M, Saeed AM, et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double-blind, placebo-controlled trial. Gastrointest Endosc. 2011;73(2):245–50.

    Article  PubMed  Google Scholar 

  86. Banares R, Albillos A, Rincon D, Alonso S, Gonzalez M, Ruiz-del-Arbol L, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology. 2002;35(3):609–15.

    Article  PubMed  Google Scholar 

  87. Villanueva C, Piqueras M, Aracil C, Gomez C, Lopez-Balaguer JM, Gonzalez B, et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol. 2006;45(4):560–7.

    Article  PubMed  Google Scholar 

  88. Avgerinos A, Armonis A, Stefanidis G, Mathou N, Vlachogiannakos J, Kougioumtzian A, et al. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology. 2004;39(6):1623–30.

    Article  PubMed  Google Scholar 

  89. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362(9):823–32.

    Article  CAS  PubMed  Google Scholar 

  90. Amitrano L, Guardascione MA, Manguso F, Bennato R, Bove A, DeNucci C, et al. The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors. Am J Gastroenterol. 2012;107(12):1872–8.

    Article  PubMed  Google Scholar 

  91. Maimone S, Saffioti F, Filomia R, Alibrandi A, Isgro G, Calvaruso V, et al. Predictors of re-bleeding and mortality among patients with refractory variceal bleeding undergoing salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS). Dig Dis Sci. 2019;64(5):1335.

    Article  PubMed  Google Scholar 

  92. Escorsell A, Pavel O, Cardenas A, Morillas R, Llop E, Villanueva C, et al. Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: a multicenter randomized, controlled trial. Hepatology. 2016;63(6):1957–67.

    Article  PubMed  Google Scholar 

  93. Shao XD, Qi XS, Guo XZ. Esophageal stent for refractory variceal bleeding: a systemic review and meta-analysis. Biomed Res Int. 2016;2016:4054513.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Garcia-Pagan JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370–9.

    Article  CAS  PubMed  Google Scholar 

  95. Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jimenez E, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004;40(4):793–801.

    Article  PubMed  Google Scholar 

  96. Garcia-Pagan JC, Di Pascoli M, Caca K, Laleman W, Bureau C, Appenrodt B, et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol. 2013;58(1):45–50.

    Article  PubMed  Google Scholar 

  97. Hernandez-Gea V, Procopet B, Giraldez A, Amitrano L, Villanueva C, Thabut D, et al. Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study. Hepatology. 2019;69(1):282–93.

    CAS  PubMed  Google Scholar 

  98. Rudler M, Cluzel P, Corvec TL, Benosman H, Rousseau G, Poynard T, et al. Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival. Aliment Pharmacol Ther. 2014;40(9):1074–80.

    Article  CAS  PubMed  Google Scholar 

  99. Thabut D, Pauwels A, Carbonell N, Remy AJ, Nahon P, Causse X, et al. Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results. J Hepatol. 2017;68(1):73–81.

    Article  PubMed  Google Scholar 

  100. Conejo I, Guardascione MA, Tandon P, Cachero A, Castellote J, Abraldes JG, et al. Multicenter external validation of risk stratification criteria for patients with variceal bleeding. Clin Gastroenterol Hepatol. 2018;16(1):132–9.. e8

    Article  PubMed  Google Scholar 

  101. Lv Y, Zuo L, Zhu X, Zhao J, Xue H, Jiang Z, et al. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study. Gut. 2019;68:1297.

    Article  CAS  PubMed  Google Scholar 

  102. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992;16(6):1343–9.

    Article  CAS  PubMed  Google Scholar 

  103. Irani S, Kowdley K, Kozarek R. Gastric varices: an updated review of management. J Clin Gastroenterol. 2011;45(2):133–48.

    Article  PubMed  Google Scholar 

  104. Bendtsen F, Krag A, Moller S. Treatment of acute variceal bleeding. Dig Liver Dis. 2008;40(5):328–36.

    Article  CAS  PubMed  Google Scholar 

  105. Hsu YC, Chung CS, Wang HP. Application of endoscopy in improving survival of cirrhotic patients with acute variceal hemorrhage. Int J Hepatol. 2011;2011:893973.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Kim T, Shijo H, Kokawa H, Tokumitsu H, Kubara K, Ota K, et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology. 1997;25(2):307–12.

    Article  CAS  PubMed  Google Scholar 

  107. Mishra SR, Sharma BC, Kumar A, Sarin SK. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. J Hepatol. 2011;54(6):1161–7.

    Article  CAS  PubMed  Google Scholar 

  108. Polio J, Groszmann RJ. Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment. Semin Liver Dis. 1986;6(4):318–31.

    Article  CAS  PubMed  Google Scholar 

  109. Watanabe K, Kimura K, Matsutani S, Ohto M, Okuda K. Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology. 1988;95(2):434–40.

    Article  CAS  PubMed  Google Scholar 

  110. Rios Castellanos E, Seron P, Gisbert JP, Bonfill CX. Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension. Cochrane Database Syst Rev. 2015;5:CD010180.

    Google Scholar 

  111. Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. “Salvage” transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology. 1998;114(5):981–7.

    Article  CAS  PubMed  Google Scholar 

  112. Procaccini NJ, Al-Osaimi AM, Northup P, Argo C, Caldwell SH. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc. 2009;70(5):881–7.

    Article  PubMed  Google Scholar 

  113. Kochhar GS, Navaneethan U, Hartman J, Mari Parungao J, Lopez R, Gupta R, et al. Comparative study of endoscopy vs. transjugular intrahepatic portosystemic shunt in the management of gastric variceal bleeding. Gastroenterol Rep (Oxf). 2015;3(1):75–82.

    Article  Google Scholar 

  114. Prachayakul V, Aswakul P, Chantarojanasiri T, Leelakusolvong S. Factors influencing clinical outcomes of Histoacryl(R) glue injection-treated gastric variceal hemorrhage. World J Gastroenterol. 2013;19(15):2379–87.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Puente A, Hernandez-Gea V, Graupera I, Roque M, Colomo A, Poca M, et al. Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review. Liver Int. 2014;34(6):823–33.

    Article  PubMed  Google Scholar 

  116. Albillos A, Zamora J, Martinez J, Arroyo D, Ahmad I, De-la-Pena J, et al. Stratifying risk in the prevention of recurrent variceal hemorrhage: results of an individual patient meta-analysis. Hepatology. 2017;66(4):1219–31.

    Article  CAS  PubMed  Google Scholar 

  117. Fagiuoli S, Bruno R, Debernardi Venon W, Schepis F, Vizzutti F, Toniutto P, et al. Consensus conference on TIPS management: techniques, indications, contraindications. Dig Liver Dis. 2017;49(2):121–37.

    Article  PubMed  Google Scholar 

  118. Gluud LL, Langholz E, Krag A. Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices. Aliment Pharmacol Ther. 2010;32(7):859–71.

    Article  CAS  PubMed  Google Scholar 

  119. Li T, Ke W, Sun P, Chen X, Belgaumkar A, Huang Y, et al. Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis. BMJ Open. 2016;6(5):e010902.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Serste T, Melot C, Francoz C, Durand F, Rautou PE, Valla D, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. 2010;52(3):1017–22.

    Article  CAS  PubMed  Google Scholar 

  121. Kim SG, Larson JJ, Lee JS, Therneau TM, Kim WR. Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates. Liver Transpl. 2017;23(6):733–40.

    Article  PubMed  PubMed Central  Google Scholar 

  122. Turco L, Villanueva C, La Mura V, Garcia-Pagan JC, Reiberger T, Genesca J, et al. A reduction in the hepatic venous pressure gradient (HVPG) prevents clinical outcomes in compensated and decompensated cirrhosis: a meta-analysis. J Hepatol. 2017;66:S95–S332.

    Article  Google Scholar 

  123. Krag A, Wiest R, Albillos A, Gluud LL. The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease. Gut. 2012;61(7):967–9.

    Article  CAS  PubMed  Google Scholar 

  124. Bang UC, Benfield T, Hyldstrup L, Jensen JE, Bendtsen F. Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers. Liver Int. 2016;36(9):1304–12.

    Article  CAS  PubMed  Google Scholar 

  125. Bossen L, Krag A, Vilstrup H, Watson H, Jepsen P. Nonselective beta-blockers do not affect mortality in cirrhosis patients with ascites: post Hoc analysis of three randomized controlled trials with 1198 patients. Hepatology. 2016;63(6):1968–76.

    Article  CAS  PubMed  Google Scholar 

  126. Leithead JA, Rajoriya N, Tehami N, Hodson J, Gunson BK, Tripathi D, et al. Non-selective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation. Gut. 2015;64(7):1111–9.

    Article  CAS  PubMed  Google Scholar 

  127. Reiberger T, Mandorfer M. Beta adrenergic blockade and decompensated cirrhosis. J Hepatol. 2017;66(4):849–59.

    Article  CAS  PubMed  Google Scholar 

  128. Mookerjee RP, Pavesi M, Thomsen KL, Mehta G, Macnaughtan J, Bendtsen F, et al. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. J Hepatol. 2016;64(3):574–82.

    Article  CAS  PubMed  Google Scholar 

  129. Reiberger T, Ferlitsch A, Payer BA, Mandorfer M, Heinisch BB, Hayden H, et al. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J Hepatol. 2013;58(5):911–21.

    Article  CAS  PubMed  Google Scholar 

  130. Senzolo M, Cholongitas E, Burra P, Leandro G, Thalheimer U, Patch D, et al. Beta-blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis. Liver Int. 2009;29(8):1189–93.

    Article  CAS  PubMed  Google Scholar 

  131. Garcia-Tsao G. Beta blockers in cirrhosis: the window re-opens. J Hepatol. 2016;64(3):532–4.

    Article  PubMed  Google Scholar 

  132. Luca A, D’Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology. 1999;212(2):411–21.

    Article  CAS  PubMed  Google Scholar 

  133. Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology. 1999;30(3):612–22.

    Article  CAS  PubMed  Google Scholar 

  134. Zheng M, Chen Y, Bai J, Zeng Q, You J, Jin R, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: meta-analysis update. J Clin Gastroenterol. 2008;42(5):507–16.

    Article  PubMed  Google Scholar 

  135. Holster IL, Tjwa ET, Moelker A, Wils A, Hansen BE, Vermeijden JR, et al. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + beta-blocker for prevention of variceal rebleeding. Hepatology. 2016;63(2):581–9.

    Article  CAS  PubMed  Google Scholar 

  136. Sauerbruch T, Mengel M, Dollinger M, Zipprich A, Rossle M, Panther E, et al. Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy. Gastroenterology. 2015;149(3):660–8; e1

    Article  PubMed  Google Scholar 

  137. Villanueva C, Graupera I, Aracil C, Alvarado E, Minana J, Puente A, et al. A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis. Hepatology. 2017;65(5):1693–707.

    Article  CAS  PubMed  Google Scholar 

  138. Abraldes JG, Villanueva C, Aracil C, Turnes J, Hernandez-Guerra M, Genesca J, et al. Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis. Gastroenterology. 2016;150(5):1160–70.. e3

    Article  CAS  PubMed  Google Scholar 

  139. Lv Y, Qi X, He C, Wang Z, Yin Z, Niu J, et al. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut. 2018;67(12):2156–68.

    Article  CAS  PubMed  Google Scholar 

  140. Amitrano L, Guardascione MA, Scaglione M, Menchise A, Martino R, Manguso F, et al. Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2012;24(12):1381–5.

    Article  CAS  PubMed  Google Scholar 

  141. Dell’Era A, Iannuzzi F, Fabris FM, Fontana P, Reati R, Grillo P, et al. Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation. Dig Liver Dis. 2014;46(2):152–6.

    Article  PubMed  Google Scholar 

  142. Zanetto A, Rodriguez-Kastro KI, Germani G, Ferrarese A, Cillo U, Burra P, et al. Mortality in liver transplant recipients with portal vein thrombosis – an updated meta-analysis. Transpl Int. 2018;31(12):1318–29.

    Article  PubMed  Google Scholar 

  143. Mishra SR, Chander Sharma B, Kumar A, Sarin SK. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. Gut. 2010;59(6):729–35.

    Article  CAS  PubMed  Google Scholar 

  144. Hung HH, Chang CJ, Hou MC, Liao WC, Chan CC, Huang HC, et al. Efficacy of non-selective beta-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: a randomized controlled trial. J Hepatol. 2012;56(5):1025–32.

    Article  CAS  PubMed  Google Scholar 

  145. Lo GH, Liang HL, Chen WC, Chen MH, Lai KH, Hsu PI, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy. 2007;39(8):679–85.

    Article  PubMed  Google Scholar 

  146. Kawanaka H. Balloon-occluded retrograde transvenous obliteration: one step beyond obliteration of gastric varices. J Gastroenterol Hepatol. 2012;27(1):3–4.

    Article  PubMed  Google Scholar 

  147. Akahoshi T, Hashizume M, Tomikawa M, Kawanaka H, Yamaguchi S, Konishi K, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol. 2008;23(11):1702–9.

    Article  PubMed  Google Scholar 

  148. Chikamori F, Kuniyoshi N, Kawashima T, Takase Y. Gastric varices with gastrorenal shunt: combined therapy using transjugular retrograde obliteration and partial splenic embolization. AJR Am J Roentgenol. 2008;191(2):555–9.

    Article  PubMed  Google Scholar 

  149. Cho SK, Shin SW, Lee IH, Do YS, Choo SW, Park KB, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. AJR Am J Roentgenol. 2007;189(6):W365–72.

    Article  PubMed  Google Scholar 

  150. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol. 2001;12(3):327–36.

    Article  CAS  PubMed  Google Scholar 

  151. Kitamoto M, Imamura M, Kamada K, Aikata H, Kawakami Y, Matsumoto A, et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. AJR Am J Roentgenol. 2002;178(5):1167–74.

    Article  PubMed  Google Scholar 

  152. Ninoi T, Nishida N, Kaminou T, Sakai Y, Kitayama T, Hamuro M, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR Am J Roentgenol. 2005;184(4):1340–6.

    Article  PubMed  Google Scholar 

  153. Hashizume M, Akahoshi T, Tomikawa M. Management of gastric varices. J Gastroenterol Hepatol. 2011;26(Suppl 1):102–8.

    Article  PubMed  Google Scholar 

  154. Hiraga N, Aikata H, Takaki S, Kodama H, Shirakawa H, Imamura M, et al. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J Gastroenterol. 2007;42(8):663–72.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Digestive Diseases Section, Yale University School of Medicine, New Haven, CT, USA

    Alberto Zanetto & Guadalupe Garcia-Tsao

  2. VA-CT Healthcare System, New Haven/West Haven, CT, USA

    Alberto Zanetto & Guadalupe Garcia-Tsao

Authors
  1. Alberto Zanetto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guadalupe Garcia-Tsao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guadalupe Garcia-Tsao .

Editor information

Editors and Affiliations

  1. Texas A&M Health Science Center, Baylor University Medical Center, Dallas, TX, USA

    Robert S. Rahimi

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zanetto, A., Garcia-Tsao, G. (2020). Gastroesophageal Variceal Bleeding Management. In: Rahimi, R. (eds) The Critically Ill Cirrhotic Patient. Springer, Cham. https://doi.org/10.1007/978-3-030-24490-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-24490-3_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-24489-7

  • Online ISBN: 978-3-030-24490-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation